Today, we’re excited to launch Feedly for Biopharma to help biopharma professionals cut through the noise. We’ve designed a collection of integrations and Leo models specifically designed to help you find the information you need, break barriers between teams, and streamline open-source intelligence.
280,000 biopharma professionals already use Feedly to keep up with the latest biopharma news and research insights about topics like diseases and conditions, genes, and competitors.
Biopharma is a competitive space. It is key for pharma and biotech companies to keep ahead of their competition and to be aware of the latest scientific and technological breakthroughs.
Learning more about the diseases and methodologies that are being researched by other biopharma companies can help you better prepare your strategic plans and research programs. According to a new analysis published in JAMA in March 2020, the cost to develop a new drug for a US biopharma company is $1 billion.
With hundreds of articles, scientific publications, and regulatory updates to read and organize every day, biopharma intelligence research is overwhelming. Finding the information you need in that sea of information is time-consuming and tedious. We’re launching Feedly for Biopharma to help biopharma professionals cut through the noise and save time.
Follow the biopharma sources you need
We’ve hand-picked the best sources in your industry to create biopharma bundles so you can keep up with trends. Choose any of the bundles below to see the different bundles of sources.
- The Biopharma Business Bundle covers the top trade publications in the biopharma sector (Endpoints, FiercePharma, BioPharma Dive, etc.)
- The Biopharma Regulatory Bundle allows you to track the latest regulatory and clinical trial updates in the biopharma sector (Eye on FDA, EMA Press Releases, Drugs.com, etc.)
- The Science Journals Bundle helps you find the best peer-review publications to follow (JAMA, Nature, ScienceDaily, The Lancet, etc.)
- The HealthTech Bundle covers digital health blogs and publications (MedCity News, Xconomy, MobiHealthNews, etc.)
Define Leo priorities based on what you’re most interested in
Leo is your AI research assistant. Ask him to read your biopharma feeds and prioritize what matters to you. Leo can recognize genes, diseases and conditions, biopharma companies and startups, topics, trends, specific events, and more.
Prioritize the diseases and conditions you are researching
Prioritize the genes you are most interested in
Track the companies and startups in your space
Break down silos
Team Boards are the private spaces where you and your team can save the best content you discover in Feedly or on the web. You can bookmark, organize, and annotate content to share insights across your team and organization.
We’ve seen teams create tactical and operational Boards. For instance, you could build a Biotech Watchlist board with information about open innovation partnerships, or a Novel Drug Approvals board to keep the team up to speed on what your competitors are developing.
Once articles have been saved to a board, you can share them to the rest of the team via daily newsletters, Slack and Microsoft Teams notifications, or push them to other apps using our API.
Streamline your biopharma intelligence
We’re excited to see how your team will declutter your feeds and dig deeper into the biopharma news that matter to you. Sign up today and discover Feedly for Biopharma.
If you’re interested in learning more about the Feedly for Biopharma roadmap, you can book a demo call by clicking on the button above. 2020 will be a thrilling year with new skills and bold experiments!
